From: Molecular imaging for evaluation of synovitis associated with osteoarthritis: a narrative review
Targets of tracers | Tracers | Â | Diseases/disease model studied | Studied for OA | ||
---|---|---|---|---|---|---|
Macrophage | TSPO | 11C-(R)-PK11195 (first generation) | Clinical | Multiple sclerosis [26], atherosclerosis [27], large vessel vasculitis [28], rheumatoid arthritis [29] | Â | |
Preclinical | Rat model of acute neuroinflammation [30] | Â | ||||
11C-vinpocetine | Clinical | Multiple sclerosis [26] | Â | |||
11C-DPA-713 | Preclinical | Rat model of acute neuroinflammation [30] Mice model of tuberculosis inflammation [31] | Â | |||
18F-DPA-714 | Preclinical | Rat model of acute neuroinflammation [30] Rat model of abdominal aneurysm [32] | Â | |||
11C-DAC | Preclinical | Rat model of autoimmune encephalomyelitis [33] | Â | |||
18F-FEDAA1106 | Clinical | Multiple sclerosis [34] | Â | |||
18F-FEDAC | Preclinical | Rat model of acute lung injury [35] | Â | |||
18F-PBR06 | Clinical | Quantification of TSPO in normal human brains [36] | Â | |||
11C-SSR180575 | Preclinical | Rat model of neuroinflammation [37] | Â | |||
18F-PBR111 | Preclinical | Rat model of temporal lobe epilepsy [38] | Â | |||
18F-GE-180 | Preclinical | Rat model of stroke [39] | Â | |||
11C PBR28 | Clinical | Â | Osteoarthritis [40] | |||
Surface receptor | Somatostatin receptor | 68Ga-DOTATATE | Clinical | Atherosclerosis [41] | Â | |
64Cu-DOTATATE | Clinical | Â | ||||
68Ga-DOTATOC | Clinical | Atherosclerosis [43] | Â | |||
68Ga-DOTANOC | Clinical | Cardiac sarcoidosis [44] | Â | |||
Macrophage mannose receptor | 99mTc-tilmanocept | Clinical | HIV related cardiovascular disease [45] | Â | ||
18F-FB-anti-MMR Ab | Preclinical | Mouse model of tumor [46] | Â | |||
99mTc-anti MMR nanobody | Preclinical | Mouse model of rheumatoid arthritis [47] | Â | |||
111In-Tilmanocept | Preclinical | Mouse model of atherosclerosis [48] | Â | |||
CXCR4 | 68Ga-Pentixafor | Preclinical | Rabbit model of atherosclerosis [49] | Â | ||
Folate receptors | 99mTc-EC20 | Clinical | Rheumatoid arthritis [50] | Osteoarthritis [51] | ||
DTPA-folate | Preclinical | Â | Rat model of osteoarthritis [52] | |||
Biologic pathways | Choline | 18F-fluorocholine | Clinical | Atherosclerosis [53] | Â | |
System XC | 18F-FSPG | Preclinical | Mice model of multiple sclerosis [54] | Â | ||
Methionine | 11C-Methionine | Clinical | Myocardial infarction [55] | Â | ||
Macrophage enzymes | iNOS: | 18F-NOS | Clinical | Acute lung inflammation [56] | Â | |
Cathepsins: | 68Ga-BMV101 | Preclinical | Mouse model of lung fibrosis, idiopathic pulmonary fibrosis [57] | Â | ||
Other macrophage specific tracers in preclinical studies | 64Cu-Man-LIPs | Preclinical | Mouse model of lung cancer [58] | Â | ||
64Cu -Cinnamoyl-F-(D)L-F-(D)L-F (cFLFLF) | Mouse model of diabetes [59] | Rat model of osteoarthritis [60] | ||||
64Cu-D-Ala1-peptied T-amide (DAPTA) | Mouse model of vascular injury [61] | Â | ||||
99mTc-NbV4m119 (CRIg-targeting nanobodies) | Mouse model of rheumatoid arthritis [62] | Â | ||||
99mTc-anti-Sn mAb (SER-4) (CD169 targeting) | Mouse model of allograft rejection [63] | Â | ||||
Anti-Vsig4 Nbs (nanobodies targeting Vsig4) | Mouse model of hepatitis [64] | Â | ||||
99mTc-labelled anti-CD11b Ab | Mouse model of atherosclerosis [65] | Â | ||||
Fibroblast | FAP inhibitor | 68Ga-FAPI | Clinical | Cancer [66], IgG4 related disease [67, 68], dilated cardiomyopathy [68] | Â | |
68Ga-DOTA-FAPI-04 | Clinical | Cancer [69] | Osteoarthritis [70] | |||
Angiogenesis | VEGF/VEGFR pathway | 89Zr-Df-bevacizumab | Clinical | Â | ||
89Zr-Df-ranibizumab | Preclinical | Mouse model of cancer [76] | Â | |||
64Cu-NOTA-RamAb | Preclinical | Mouse model of cancer [77] | Â | |||
αvβ3-integrin | 18F-FPRGD2 | Preclinical | Cancer [78] |  | ||
Clinical | Â | Osteoarthritis [79] | ||||
68Ga-PRDG2 | Clinical | Â | Osteoarthritis [80] |